| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.0094 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |